Exclusive: charities say people with weakened immunity falling critically ill after struggling to access treatments on NHS
Cancer patients infected with coronavirus in England are becoming seriously ill after they were unable to access antibody or antiviral medicines on the NHS.
Ministers have promised to provide early treatment for 1.3 million people whose immune systems mean they are at higher risk of severe disease, hospitalisation or death. The treatments include the monoclonal antibody sotrovimab (Xevudy) and the antiviral medicines nirmatrelvir and ritonavir (Paxlovid), remdesivir (Veklury), and molnupiravir (Lagevrio).
